Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Shawn Yu, Master
CONTACT
Lead
Genor Biopharma Co., Ltd.
With
In this study, it is planned to enroll at least 42 NSCLC patients who meet relevant criteria. This study includes dose escalation phase and extension phase of the combined therapy: three combined dose groups are planned in the dose escalation phase; the dose extension phase is divided into two cohorts.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted